Real-world diagnostic outcomes and cost-effectiveness of genome-wide sequencing for developmental and seizure disorders: Evidence from Canada
- Dean A. Regier
- , Rosalie Loewen
- , Brandon Chan
- , Morgan Ehman
- , Samantha Pollard
- , Jan M. Friedman
- , Sylvia Stockler-Ipsiroglu
- , Clara van Karnebeek
- , Simone Race
- , Alison M. Elliott
- , Nick Dragojlovic
- , Larry D. Lynd
- , Deirdre Weymann*
*Corresponding author for this work
- Faculty of Medicine, University of British Columbia School of Medicine, Vancouver, British Columbia, Canada
- Canada’s Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, BC, V5Z4S6, Canada
- University of British Columbia
- Centre for Health Evaluation and Outcomes Sciences, Providence Health Research Institute, Canada
Research output: Contribution to journal › Article › Academic › peer-review
48
Downloads
(Pure)